These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29277558)

  • 1. The cohort multiple randomized controlled trial design was found to be highly susceptible to low statistical power and internal validity biases.
    Reeves D; Howells K; Sidaway M; Blakemore A; Hann M; Panagioti M; Bower P
    J Clin Epidemiol; 2018 Mar; 95():111-119. PubMed ID: 29277558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study.
    Candlish J; Pate A; Sperrin M; van Staa T;
    BMC Med Res Methodol; 2017 Jan; 17(1):17. PubMed ID: 28143408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design.
    Pate A; Candlish J; Sperrin M; Van Staa TP;
    BMC Med Res Methodol; 2016 Aug; 16(1):109. PubMed ID: 27566594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review of the Statistical Methods Adopted for Analyzing Follow-Up Data in Cohort Multiple Randomized Controlled Trial.
    Narzari H; Nilima N; Vishnu VY; Khan MA; Gupta A; Srivastava VP
    Cureus; 2024 Jan; 16(1):e51558. PubMed ID: 38313924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and challenges of using the cohort multiple randomised controlled trial design for testing an intervention for depression.
    Viksveen P; Relton C; Nicholl J
    Trials; 2017 Jul; 18(1):308. PubMed ID: 28683809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results.
    Young-Afat DA; van Gils CH; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2017 Jul; 164(2):445-450. PubMed ID: 28444532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cohort multiple randomized controlled trial: a solution for the evaluation of multiple interventions].
    Verkooijen HM; Roes K; van Gils CH
    Ned Tijdschr Geneeskd; 2013; 157(17):A5762. PubMed ID: 23614865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
    van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
    Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design.
    Clegg A; Relton C; Young J; Witham M
    Age Ageing; 2015 Jul; 44(4):547-50. PubMed ID: 25857552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some main problems eroding the credibility and relevance of randomized trials.
    Ioannidis JP
    Bull NYU Hosp Jt Dis; 2008; 66(2):135-9. PubMed ID: 18537784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review.
    Amstutz A; Schönenberger CM; Speich B; Griessbach A; Schwenke JM; Glasstetter J; James S; Verkooijen HM; Nickolls B; Relton C; Hemkens LG; Chammartin F; Gerber F; Labhardt ND; Schandelmaier S; Briel M
    J Clin Epidemiol; 2024 Oct; 174():111469. PubMed ID: 39032590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Power and Sample Size Calculation in Rehabilitation Trial Reports: A Methodological Assessment.
    Castellini G; Gianola S; Bonovas S; Moja L
    Arch Phys Med Rehabil; 2016 Jul; 97(7):1195-201. PubMed ID: 26971671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting.
    Gal R; Monninkhof EM; van Gils CH; Groenwold RHH; van den Bongard DHJG; Peeters PHM; Verkooijen HM; May AM
    J Clin Epidemiol; 2019 Sep; 113():137-146. PubMed ID: 31146022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Controlled Trials 6: Determining the Sample Size and Power for Clinical Trials and Cohort Studies.
    Greene T
    Methods Mol Biol; 2021; 2249():281-305. PubMed ID: 33871850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.
    Coebergh van den Braak RRJ; van Rijssen LB; van Kleef JJ; Vink GR; Berbee M; van Berge Henegouwen MI; Bloemendal HJ; Bruno MJ; Burgmans MC; Busch ORC; Coene PPLO; Coupé VMH; Dekker JWT; van Eijck CHJ; Elferink MAG; Erdkamp FLG; van Grevenstein WMU; de Groot JWB; van Grieken NCT; de Hingh IHJT; Hulshof MCCM; Ijzermans JNM; Kwakkenbos L; Lemmens VEPP; Los M; Meijer GA; Molenaar IQ; Nieuwenhuijzen GAP; de Noo ME; van de Poll-Franse LV; Punt CJA; Rietbroek RC; Roeloffzen WWH; Rozema T; Ruurda JP; van Sandick JW; Schiphorst AHW; Schipper H; Siersema PD; Slingerland M; Sommeijer DW; Spaander MCW; Sprangers MAG; Stockmann HBAC; Strijker M; van Tienhoven G; Timmermans LM; Tjin-A-Ton MLR; van der Velden AMT; Verhaar MJ; Verkooijen HM; Vles WJ; de Vos-Geelen JMPGM; Wilmink JW; Zimmerman DDE; van Oijen MGH; Koopman M; Besselink MGH; van Laarhoven HWM;
    Acta Oncol; 2018 Feb; 57(2):195-202. PubMed ID: 28723307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI.
    Braakhekke M; Scholten I; Mol F; Limpens J; Mol BW; van der Veen F
    Hum Reprod; 2017 Oct; 32(10):2117-2122. PubMed ID: 28938740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II error and statistical power in reports of small animal clinical trials.
    Giuffrida MA
    J Am Vet Med Assoc; 2014 May; 244(9):1075-80. PubMed ID: 24739118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design.
    Young-Afat DA; Verkooijen HA; van Gils CH; van der Velden JM; Burbach JP; Elias SG; van Delden JJ; Relton C; van Vulpen M; van der Graaf R
    Epidemiology; 2016 May; 27(3):389-92. PubMed ID: 27035689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.